Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Clinical and Diagnostic Laboratory Immunology|July 7, 2000
Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assayT Messele, M T Roos, D Hamann, et al.
The Journal of Infectious Diseases|July 29, 2000
Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humansM T Roos, R A van Lier, D Hamann, et al.
Journal of Neuroimmunology|November 26, 2002
Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-betaJ Killestein, R Q Hintzen, B M J Uitdehaag, et al.
AIDS (London, England)|January 1, 1991
Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug usersG H Mientjes, F Miedema, E J van Ameijden, et al.
AIDS Research and Human Retroviruses|March 20, 1997
Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individualsM R Klein, J Veenstra, A M Holwerda, et al.
Ultrasound in Medicine & Biology|May 11, 2016
Unexpected High Incidence of Coronary Vasoconstriction in the Reduction of Microvascular Injury Using Sonolysis (ROMIUS) TrialSebastiaan T Roos, Lynda J M Juffermans, Niels van Royen, et al.
Environmental Research|February 14, 2024
A systematic review and meta-analysis of human population studies on the association between exposure to toxic environmental chemicals and left ventricular dysfunction (LVD)G Donzelli, F Sera, M A Morales, et al.
Clinical and Experimental Immunology|September 1, 1996
Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expressionM T Roos, F Miedema, A P Meinesz, et al.
AIDS (London, England)|November 1, 1992
Large diurnal variation in CD4 cell count and T-cell function among drug users: implications for clinical practice and epidemiological studiesG H Mientjes, E J van Ameijden, M T Roos, et al.
Journal of Neuroimmunology|May 5, 1999
Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patientsM H Rep, H M Schrijver, T van Lopik, et al.
Pageof 10